Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (2 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
COVID-19 (3)
Type
(
1 selected
)
Type
Guidance (761)
Guidance programme
(
1 selected
)
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (223)
COVID-19 rapid guidelines (3)
Diagnostics guidance (47)
Health technology evaluations (18)
Highly specialised technologies guidance (28)
Interventional procedures guidance (601)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (339)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (761)
Apply filters
Showing 701 to 710 of 761
Sort by
Date
Title
Apply sorting
Type: Guidance
Remove Type: Guidance filter
Guidance programme: Technology appraisal guidance
Remove Guidance programme: Technology appraisal guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Pemetrexed for the first-line treatment of non-small-cell lung cancer
TA181
23 September 2009
23 September 2009
Alitretinoin for the treatment of severe chronic hand eczema
TA177
26 August 2009
26 August 2009
Bevacizumab (first-line), sorafenib (first- and second-line), sunitinib (second-line) and temsirolimus (first-line) for the treatment of advanced and/or metastatic renal cell carcinoma
TA178
26 August 2009
26 August 2009
Tenofovir disoproxil for the treatment of chronic hepatitis B
TA173
22 July 2009
22 July 2009
Rituximab for the first-line treatment of chronic lymphocytic leukaemia
TA174
22 July 2009
22 July 2009
Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults
TA170
22 April 2009
22 April 2009
Sunitinib for the first-line treatment of advanced and/or metastatic renal cell carcinoma
TA169
25 March 2009
25 March 2009
Amantadine, oseltamivir and zanamivir for the treatment of influenza
TA168
25 February 2009
25 February 2009
Machine perfusion systems and cold static storage of kidneys from deceased donors
TA165
28 January 2009
28 January 2009
Infliximab for acute exacerbations of ulcerative colitis
TA163
17 December 2008
17 December 2008
Previous page
1
…
69
70
Current page
71
72
73
…
77
Page
71
of
77
Next page
Results per page
10
25
50
All
Back to top